Regulus Therapeutics Inc (NASDAQ:RGLS)
| 0.31 Delayed Data As of May 27 |  +0.0345 / +12.52%Today’s Change | 0.16 Today|||52-Week Range 1.48 | -1.59% Year-to-Date |
Institutional investors purchased a net $26.3 million shares of RGLS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 33.53% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
| Mutual fund holders | 8.55% |
| Other institutional | 24.98% |
| Individual stakeholders | 10.73% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2022 | FEDERATED GLOBAL INVESTMENT MANA... Bought 29.0 Million shares of Regulus Therapeutics Inc |
| 3/31/2022 | THE VANGUARD GROUP, INC. Bought 648.1 Thousand shares of Regulus Therapeutics Inc |
| 3/31/2022 | RENAISSANCE TECHNOLOGIES LLC Bought 111.1 Thousand shares of Regulus Therapeutics Inc |
Top 10 Owners of Regulus Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Federated Global Investment Manag... | 19.90% | 29,048,265 | 5,838,701 | +29,048,265 | -- |
| DAFNA Capital Management LLC | 3.81% | 5,555,555 | 1,116,667 | 0 | 0.00% |
| The Vanguard Group, Inc. | 2.50% | 3,646,859 | 733,019 | +648,121 | +21.61% |
| Asymmetry Capital Management LP | 1.87% | 2,731,044 | 548,940 | +1,329,553 | +94.87% |
| Victory Capital Management, Inc. ... | 1.53% | 2,233,031 | 448,839 | -513 | -0.02% |
| Sarissa Capital Management LP | 1.27% | 1,851,851 | 372,222 | 0 | 0.00% |
| Ikarian Capital LLC | 0.88% | 1,289,130 | 259,115 | +60,714 | +4.94% |
| Geode Capital Management LLC | 0.45% | 649,070 | 130,463 | +59,874 | +10.16% |
| T. Rowe Price Associates, Inc. (I... | 0.13% | 184,600 | 37,105 | 0 | 0.00% |
| SSgA Funds Management, Inc. | 0.12% | 176,494 | 35,475 | 0 | 0.00% |
Top 10 Mutual Funds Holding Regulus Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| USAA Science & Technology Fund | 4.30% | 6,270,099 | 1,260,290 | 0 | 0.00% |
| Vanguard Total Stock Market Index... | 1.71% | 2,495,945 | 501,685 | 0 | 0.00% |
| Victory RS Science & Technology F... | 1.21% | 1,768,489 | 355,466 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 0.79% | 1,150,914 | 231,334 | 0 | 0.00% |
| Fidelity Extended Market Index Fu... | 0.25% | 357,422 | 71,842 | 0 | 0.00% |
| AST T Rowe Price Growth Opportuni... | 0.13% | 184,600 | 37,105 | 0 | 0.00% |
| Fidelity Series Total Market Inde... | 0.05% | 71,542 | 14,380 | 0 | 0.00% |
| Fidelity Nasdaq Composite Index F... | 0.05% | 67,351 | 13,538 | 0 | 0.00% |
| Fidelity Total Market Index Fund | 0.04% | 50,761 | 10,203 | 0 | 0.00% |
| Vanguard Invt. Fds. ICVC - US Equ... | 0.02% | 31,475 | 6,326 | 0 | 0.00% |